Stock Evaluator: Ryman Healthcare Limited (RYHTY)
Ryman Healthcare Limited RYHTY
$5.06
-0.08
-1.46%
November 6, 2026 12:29:09 PM
EST
Volume: 394
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company’s villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.
Financial Summary
| Share Statistics | RYHTY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,034.0 | $1,904.5 | 46% |
|
| Shares Out (Mil) | 580.4 | 79.2 | 89% |
|
| Institutional Ownership | 49.9% | 86.0% | 27% |
|
| Float (Mil) | 1,004.7 | 58.8 | 91% |
|
| Beta | 0.34 | 0.75 | 20% |
|
| Avg Daily Volume (000s) | 0 | 722 | 0% |
|
| Price Change (52-week) |
(86.2%) | 82.2% | 7% |
|
| Growth | RYHTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.9% | 10.3% | 54% |
|
| Net Income (5yr) | (18.4%) | (0.7%) | 22% |
|
| EPS (5yr) | (16.7%) | 2.1% | 16 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | 19.7% | (17.4%) | 79% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RYHTY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $488 | $1,505 | 40% |
|
| Net Income (TTM) (Mil) | ($98) | $32 | 11% |
|
| EPS (TTM) | ($0.096) | $0.300 | 35% |
|
| Operating Cash Flow (TTM) (Mil) | $191 | $160 | 58% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $2 | 35% |
|
| Long-Term Debt (Q1) (Mil) | $912 | $421 | 65% |
|
| Enterprise Value (Q1) (Mil) | $2,119 | $2,459 | 50% |
|
| Valuation | RYHTY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.84 | na |
|
| P/E | na | 27.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | RYHTY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 9.5% | 27.9% | 9% |
|
| Net Margin | (20.1%) | 1.4% | 16% |
|
| ROA | (1.4%) | 2.2% | 35% |
|
| ROE | (4.2%) | 6.9% | 31% |
|
| Liabilities to Assets | 66.8% | 61.2% | 63% |
|
| F-Score | na | 5 | na |
|
Ryman Healthcare Limited did not pass any screens on 11/6/2026.
